» Authors » W C Schumann

W C Schumann

Explore the profile of W C Schumann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 1061
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoybye C, Chandramouli V, Efendic S, Hulting A, Landau B, Schumann W, et al.
Horm Metab Res . 2008 Apr; 40(7):498-501. PMID: 18393170
The diabetogenic effect of excess growth hormone (GH) such as that in acromegaly is well known. However, the contribution of the various components to hepatic glucose production (HGP) is not...
2.
Stingl H, Chandramouli V, Schumann W, Brehm A, Nowotny P, Waldhausl W, et al.
Diabetologia . 2005 Dec; 49(2):360-8. PMID: 16380802
Aims/hypothesis: Glycogen cycling, i.e. simultaneous glycogen synthesis and glycogenolysis, affects estimates of glucose fluxes using tracer techniques and may contribute to hyperglycaemia in diabetic conditions. This study presents a new...
3.
Schumann W, Gastaldelli A, Chandramouli V, Previs S, Pettiti M, Ferrannini E, et al.
Anal Biochem . 2001 Oct; 297(2):195-7. PMID: 11673889
No abstract available.
4.
Jensen M, Chandramouli V, Schumann W, Ekberg K, Previs S, Gupta S, et al.
Am J Physiol Endocrinol Metab . 2001 Oct; 281(5):E998-1004. PMID: 11595656
To determine the source(s) of blood and very low density lipoprotein (VLDL)-triglyceride glycerol during fasting, four men ingested (2)H(2)O from 14 to 20 h into a 60-h fast to achieve...
5.
Edgerton D, Cardin S, Emshwiller M, Neal D, Chandramouli V, Schumann W, et al.
Diabetes . 2001 Jul; 50(8):1872-82. PMID: 11473051
Based on our earlier work, a 2.5-fold increase in insulin secretion should completely inhibit hepatic glucose production through the hormone's direct effect on hepatic glycogen metabolism. The aim of the...
6.
Wajngot A, Chandramouli V, Schumann W, Ekberg K, Jones P, Efendic S, et al.
Metabolism . 2001 Feb; 50(1):47-52. PMID: 11172474
Contributions of gluconeogenesis to glucose production were determined between 14 to 22 hours into a fast in type 2 diabetics (n = 9) and age-weight-matched controls (n = 7); ages,...
7.
Nielsen M, Nyholm B, Caumo A, Chandramouli V, Schumann W, Cobelli C, et al.
Diabetes . 2000 Dec; 49(12):2135-41. PMID: 11118017
Impaired glucose effectiveness (i.e., a diminished ability of glucose per se to facilitate its own metabolism), increased gluconeogenesis, and endogenous glucose release are, together with insulin resistance and beta-cell abnormalities,...
8.
Hundal R, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, et al.
Diabetes . 2000 Dec; 49(12):2063-9. PMID: 11118008
To examine the mechanism by which metformin lowers endogenous glucose production in type 2 diabetic patients, we studied seven type 2 diabetic subjects, with fasting hyperglycemia (15.5 +/- 1.3 mmol/l),...
9.
Wajngot A, Chandramouli V, Schumann W, Brunengraber H, Efendic S, Landau B
Metabolism . 2000 Oct; 49(9):1211-4. PMID: 11016906
Phenylacetate ingestion has been used to probe Krebs cycle metabolism and to augment waste nitrogen excretion in urea cycle disorders. Phenylalkanoic acids, including phenylacetate, have been proposed as potential therapeutic...
10.
Roden M, Stingl H, Chandramouli V, Schumann W, Hofer A, Landau B, et al.
Diabetes . 2000 Jul; 49(5):701-7. PMID: 10905476
Effects of free fatty acids (FFAs) on endogenous glucose production (EGP) and gluconeogenesis (GNG) were examined in healthy subjects (n = 6) during stepwise increased Intralipid/heparin infusion (plasma FFAs 0.8+/-0.1,...